Upon suspension of the trading of its Common Stock on Nasdaq, the Company expects that its Common Stock will be quoted under ...

Overall, the hazard ratio for in-hospital mortality at 28 days was 0.73 (95% confidence interval, 0.56 to 0.96) compared to ...

The administration of U.S. President Donald Trump is making life difficult for academics and scientific researchers. Many are looking to leave the country as a result. We spoke with four of them.

In a statement today, the company said it supports recent precautionary measures and that thorough investigations are needed ...

When you buy something by clicking links within this article, we may earn a small commission, but it never affects the ...

Novavax is undervalued, presenting an attractive risk-reward profile for long-term investors. Click here to find out why NVAX ...

Zynex, Inc. (NASDAQ: ZYXI), an innovative medical technology company specializing in the manufacture and sale of ...

Improvements in our understanding of the human genome, technological tools like artificial intelligence, and global ...

The FDA has chosen Dr Vinay Prasad, a professor at UCSF, to lead its Center for Biologics Evaluation and Research.

Meanwhile, health secretary Robert F. Kennedy Jr. and his lieutenants have sent multiple signals in recent weeks that they ...

Kimera Labs, Inc., the pioneer in therapeutic exosome biotechnology, is proud to announce its selection as a semifinalist in ...

Multiple HCPs have requested from Invivyd a monoclonal antibody (mAb) for treatment of active measles infection and post-exposure prophylaxis to reduce the consequence of outbreaks. Such a medicine ...